Try the all-new QuickBooks Online for FREE.  No credit card required.

Quiz- Osteoporosis - College of Pharmacy

Document Sample
Quiz- Osteoporosis - College of Pharmacy Powered By Docstoc
					                                      College of Pharmacy

ACPE # 0012-0000-10-077-H01-P for pharmacists and 0012-0000-10-077-H01-T for pharmacy

1. Which of the following T-scores indicates Osteoporosis?
             a. T-score > -1
             b. -2.5 < T-score < -1
             c. T-score < -2.5
             d. T-score > 2.5

2. A known risk factor for osteoporosis is:
             a. Chronic glucocorticoid use
             b. African-American race
             c. History of cancer
             d. Obesity

3. The gold standard of measuring bone mineral density is:
              a. “DXA” scan of femoral neck or spine
              b. Standard x-ray of the spine
              c. Serum markers of bone turnover
              d. MRI

4. According to the National Osteoporosis Foundation recommendations, in which of the
   following patients would bone mineral density testing be most indicated?
              a. A 25-year old pre-menopausal woman who fractured her leg in a skiing
              b. A 55-year old post-menopausal woman with no significant PMH presenting
                  for her annual gynecologic exam
              c. A 66-year old post-menopausal woman on chronic prednisone due to
                  rheumatoid arthritis
              d. A 40-year old man who fractured his wrist

5. Risk factors associated with osteonecrosis of the jaw and bisphosphonate use include all of
   the following except:
              a. Age over 65
              b. Periodontitis
              c. Tooth extraction
              d. Low body mass

6. Regarding serum calcium homeostasis, the effects of calcitonin are opposite those of which

              a. Parathyroid hormone
              b. Estrogen
              c. Follicle-stimulating hormone
              d. Serotonin

7. The recommended daily dose of Calcium/Vitamin D for patients over age 50 is
            a. 1200 mg Calcium/800-1000 IU Vitamin D
            b. 1000 mg Calcium/800-1000 IU Vitamin D
            c. 800-1000 IU Calcium/1200 mg Vitamin D
            d. 1200 mg Calcium/600 IU Vitamin D

8. Long-term effects of teriparatide are not known, and the recommended maximum duration of
   use should not exceed:
              a. 12 months
              b. 24 months
              c. 36 months
              d. There is no limit to how long teriparatide can be used

9. Regarding HRT for prevention of osteoporosis, which of the following statements most
   reflects the position of the North American Menopause Society?
               a. It should never be considered under any circumstance
               b. It has been shown to be safer if initiated at least 5-10 years post-menopause
               c. It may be considered for women with intolerable symptoms of menopause
                   who would also benefit from osteoporosis prevention
               d. There have been no major adverse effects seen with HRT in post-menopause

10. The National Osteoporosis Foundation’s recommendation for initiating pharmacologic
    treatment for fracture risk reduction in post-menopausal women and men over age 50 include
    all of the following except:
                 a. Patient has had experienced a femoral neck or vertebral fracture
                 b. Patient with a T-score of < -2.5 who has been properly evaluated to exclude
                    secondary causes of osteoporosis
                 c. Patient with a ten year probability of a hip fracture > 3 % or a ten year
                    probability of a major osteoporosis-related fracture > 20 % based on the
                    FRAX tool AND a T-score between -1 and – 2.5
                 d. Patient is unable to achieve the recommended daily dose of Calcium and
                    Vitamin D


Shared By: